Can Fite Biopharma Ltd (CANF) — Long-term Investment Intensity
Can Fite Biopharma Ltd (CANF) has a Long-term Investment Intensity of 9.9% as of September 2018. Long-term investments of ILA1.08 Million represent 9.9% of total assets of ILA10.82 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See CANF net assets for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Can Fite Biopharma Ltd Long-term Investment Intensity (2017–2017)
This chart shows how Can Fite Biopharma Ltd's Long-term Investment Intensity has evolved across 1 annual periods from 2017 to 2017. As of September 2018, the intensity stands at 9.9%, reflecting long-term investments of ILA1.08 Million against total assets of ILA10.82 Million ILA. Also explore Can Fite Biopharma Ltd total assets for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Can Fite Biopharma Ltd (2017–2017)
The table below presents the year-by-year Long-term Investment Intensity for Can Fite Biopharma Ltd from 2017 to 2017, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see how much is Can Fite Biopharma Ltd worth.
| Year | LT Investment Intensity | LT Investments (ILA) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2017 | 11.7% | ILA914.66K | ILA7.83 Million | — |